{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:20:56Z","timestamp":1790000456795,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Avoidance of unnecessary antimicrobial administration is a key tenet of antimicrobial stewardship; knowing the optimal duration of therapy obviates over-treatment. However, little research has been performed to establish course lengths for common canine infections. In clinical practice, antimicrobial therapy is frequently prescribed in dogs presenting lower urinary tract signs (haematuria, pollakiuria and dysuria\/stranguria). The proposed length of treatment in International Consensus guidelines has decreased with each iteration, but these recommendations remain arbitrary and largely extrapolated from experience in people.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The objective of this prospective, multi-centre study is to find the shortest course duration that is non-inferior to the standard duration of 7 days of amoxicillin\/clavulanate in terms of clinical outcomes for female dogs with lower urinary tract signs consistent with a urinary tract infection. An electronic data capture platform will be used by participating veterinarians working in clinical practice in the United Kingdom. Eligible dogs must be female, aged between 6 months and 10 years and have lower urinary tract signs of up to seven days\u2019 duration. Enrolment will be offered in cases where the case clinician intends to prescribe antimicrobial therapy. Automatic pseudo-randomisation to treatment group will be based on the day of presentation (Monday-Friday); all antimicrobial courses will be completed on the Sunday after presentation generating different treatment durations. Follow-up data will be collected 1, 8 and 22\u201326 days after completion of the antimicrobial course to ensure effective safety netting, and to monitor short-term outcome and recurrence rates. Informed owner consent will be obtained in all cases. The study is approved by the Ethical Review Board of the University of Nottingham and has an Animal Test Certificate from the Veterinary Medicine\u2019s Directorate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study has been designed to mirror current standards of clinical management; conclusions should therefore, be widely applicable and guide practising veterinarians in their antimicrobial decision-making process. A duration-response curve will be created allowing determination of the optimal treatment duration for the management of female dogs with lower urinary tract signs. It is hoped that these results will contribute valuable information to improve future antimicrobial stewardship as part of a wider one-health perspective.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-021-02974-y","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T15:03:17Z","timestamp":1630940597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prospective trial of different antimicrobial treatment durations for presumptive canine urinary tract infections"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4856-3307","authenticated-orcid":false,"given":"Fergus","family":"Allerton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen B.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bazelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Caddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andria","family":"Cauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"De Risio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Swann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Warland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"issue":"1","key":"2974_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, Diaz H\u00f6gberg L, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366.","journal-title":"Lancet Infect Dis"},{"key":"2974_CR2","volume-title":"Antimicrobial Use Guidelines for Companion Animal Practice [Antibiotikavejledning til familiedyr]","author":"LR Jessen","year":"2018","unstructured":"Jessen LR, Damborg P, Spohr A, et al. Antimicrobial Use Guidelines for Companion Animal Practice [Antibiotikavejledning til familiedyr]. 2nd ed. Copenhagen: Den Danske Dyrl\u00e6geforenings Sektion for Hund; 2018.","edition":"2"},{"key":"2974_CR3","doi-asserted-by":"publisher","first-page":"163-e43","DOI":"10.1111\/vde.12118","volume":"25","author":"A Hillier","year":"2014","unstructured":"Hillier A, Lloyd DH, Weese JS, et al. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). Vet Dermatol. 2014;25:163-e43.","journal-title":"Vet Dermatol"},{"issue":"2","key":"2974_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/jvim.14627","volume":"31","author":"MR Lappin","year":"2017","unstructured":"Lappin MR, Blondeau J, Boothe D, et al. Antimicrobial use guidelines for treatment of respiratory tract disease in dogs and cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. J Vet Intern Med. 2017;31(2):279\u201394.","journal-title":"J Vet Intern Med"},{"key":"2974_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tvjl.2019.02.008","volume":"247","author":"JS Weese","year":"2019","unstructured":"Weese JS, Blondeau J, Boothe D, et al. International Society for companion animal infectious diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. Vet J. 2019;247:8\u201325.","journal-title":"Vet J"},{"key":"2974_CR6","doi-asserted-by":"publisher","first-page":"e000370","DOI":"10.1136\/vetreco-2019-000370","volume":"7","author":"B Lutz","year":"2020","unstructured":"Lutz B, Lehner C, Schmitt K, et al. Antimicrobial prescriptions and adherence to prudent use guidelines for selected canine diseases in Switzerland in 2016. Vet Rec Open. 2020;7:e000370.","journal-title":"Vet Rec Open"},{"issue":"9","key":"2974_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/vr.155.9.259","volume":"155","author":"M Rantala","year":"2004","unstructured":"Rantala M, Huovinen P, Holso K, Lilas A, Kaartinen L. Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec. 2004;155(9):259\u201362.","journal-title":"Vet Rec"},{"key":"2974_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fvets.2018.00309","volume":"5","author":"B G\u00f3mez-Poveda","year":"2018","unstructured":"G\u00f3mez-Poveda B, Moreno MA. Antimicrobial Prescriptions for Dogs in the Capital of Spain. Front Vet Sci. 2018;5:309.","journal-title":"Front Vet Sci"},{"issue":"13","key":"2974_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/vr.102462","volume":"175","author":"N De Briyne","year":"2014","unstructured":"De Briyne N, Atkinson J, Pokludov\u00e1 L, Borriello SP. Antimicrobials used most commonly to treat animals in Europe. Vet Rec. 2014;175(13):325.","journal-title":"Vet Rec"},{"key":"2974_CR10","first-page":"1162","volume":"10","author":"GV Ling","year":"1984","unstructured":"Ling GV. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract. J Am Vet Med Assoc. 1984;10:1162\u20134.","journal-title":"J Am Vet Med Assoc"},{"key":"2974_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/00480169.2017.1316529","volume":"65","author":"KK Adamama-Moraitou","year":"2017","unstructured":"Adamama-Moraitou KK, Pardali D, Prassinos NN, et al. Evaluation of dogs with macroscopic haematuria: a retrospective study of 162 cases (2003\u20132010). N Z Vet J. 2017;65:204\u20138.","journal-title":"N Z Vet J"},{"issue":"11","key":"2974_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1748-5827.1977.tb05843.x","volume":"18","author":"A-K Kivist\u00d6","year":"1977","unstructured":"Kivist\u00d6 A-K, Vasenius H, Sandholm M. Canine bacteruria. J Small Anim Pract. 1977;18(11):707\u201312.","journal-title":"J Small Anim Pract"},{"key":"2974_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/jvim.15048","volume":"32","author":"TM S\u00f8rensen","year":"2018","unstructured":"S\u00f8rensen TM, Bj\u00f8rnvad CR, Cordoba G, et al. Effects of diagnostic work-up on medical decision-making for canine urinary tract infection: an observational study in Danish small animal practices. J Vet Intern Med. 2018;32:743\u201351.","journal-title":"J Vet Intern Med"},{"key":"2974_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12917-014-0217-4","volume":"10","author":"U Windahl","year":"2014","unstructured":"Windahl U, Holst BS, Nyman A, et al. Characterisation of bacterial growth and antimicrobial susceptibility patterns in canine urinary tract infections. BMC Vet Res. 2014;10:217.","journal-title":"BMC Vet Res"},{"key":"2974_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tvjl.2019.03.003","volume":"247","author":"TM S\u00f8rensen","year":"2019","unstructured":"S\u00f8rensen TM, Holmslykke M, Nordlund M, Siersma V, Jessen LR. Pre-test probability of urinary tract infection in dogs with clinical signs of lower urinary tract disease. Vet J. 2019;247:65\u201370.","journal-title":"Vet J"},{"key":"2974_CR16","doi-asserted-by":"crossref","unstructured":"Weese JS, Blondeau JM, Boothe D, et al. Antimicrobial use guidelines for treatment of urinary tract disease in dogs and cats: Antimicrobial guidelines working group of the international society for companion animal infectious diseases. Vet Med Int. 2011;2011(4):1\u20139.","DOI":"10.4061\/2011\/263768"},{"key":"2974_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1559-2","volume":"16","author":"D Ironmonger","year":"2016","unstructured":"Ironmonger D, Edeghere O, Gossain S, Hawkey. PM Use of antimicrobial resistance information and prescribing guidance for management of urinary tract infections: survey of general practitioners in the West Midlands. BMC Infect Dis. 2016;16:1\u20136.","journal-title":"BMC Infect Dis"},{"issue":"e41","key":"2974_CR18","first-page":"1","volume":"20","author":"KMJ Ganzeboom","year":"2019","unstructured":"Ganzeboom KMJ, Uijen AA, Teunissen DTAM, Assendelft WJJ, Peters HJG, Hautvast JLA, Van Jaarsveld CHM. Urine cultures and antimicrobials for urinary tract infections in Dutch general practice. Prim Health Care Res Dev. 2019;20(e41):1\u20138.","journal-title":"Prim Health Care Res Dev"},{"key":"2974_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12875-020-01305-8","volume":"21","author":"M Spek","year":"2020","unstructured":"Spek M, Cals JWL, Oudhuis GJ, et al. Workload, diagnostic work-up and treatment of urinary tract infections in adults during out-of-hours primary care: a retrospective cohort study. BMC Fam Pract. 2020;21:231.","journal-title":"BMC Fam Pract"},{"issue":"6","key":"2974_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/1098612X16656706","volume":"19","author":"S Burke","year":"2016","unstructured":"Burke S, Black V, S\u00e1nchez-Vizca\u00edno F, Radford A, Hibbert A, Tasker S. Use of cefovecin in a UK population of cats attending first-opinion practices as recorded in electronic health records. J Feline Med Surg. 2016;19(6):687\u201392.","journal-title":"J Feline Med Surg"},{"key":"2974_CR21","unstructured":"European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) report. Sales of veterinary antimicrobial agents in 31 European countries in 2018. 2020.\u00a0https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2018-trends-2010-2018-tenth-esvac-report_en.pdf."},{"key":"2974_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1748-5827.2011.01098.x","volume":"52","author":"A Mateus","year":"2011","unstructured":"Mateus A, Brodbelt DC, Barber N, St\u00e4rk. KDC Antimicrobial usage in dogs and cats in first opinion veterinary practices in the UK. J Small Anim Pract. 2011;52:515\u201321.","journal-title":"J Small Anim Pract"},{"key":"2974_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/vr.101482","volume":"173","author":"JL Hall","year":"2013","unstructured":"Hall JL, Holmes MA, Baines SJ. Prevalence and antimicrobial resistance of canine urinary tract pathogens. Vet Rec. 2013;173:549.","journal-title":"Vet Rec"},{"issue":"4","key":"2974_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/jvim.13571","volume":"29","author":"C Wong","year":"2015","unstructured":"Wong C, Epstein SE, Westropp JL. Antimicrobial susceptibility patterns in urinary tract infections in dogs (2010\u20132013). J Vet Intern Med. 2015;29(4):1045\u2013105.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"2974_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5326\/JAAHA-MS-5944","volume":"49","author":"N Smee","year":"2013","unstructured":"Smee N, Lloyd K, Grauer GF. UTIs in Small Animal Patients: Part 2: Diagnosis, Treatment, and Complications. J Am Anim Hosp Assoc. 2013;49(2):83\u201394.","journal-title":"J Am Anim Hosp Assoc"},{"key":"2974_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1748-5827.1995.tb02948.x","volume":"36","author":"JP Cotard","year":"1995","unstructured":"Cotard JP, Gruet P, Pechereau D, Moreau P, et al. Comparative study of marbofloxacin and amoxicillin clavulanic acid in the treatment of urinary tract infections in dogs. J Small Anim Pract. 1995;36:349\u201353.","journal-title":"J Small Anim Pract"},{"issue":"3","key":"2974_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1939-1676.2012.00914.x","volume":"26","author":"JL Westropp","year":"2012","unstructured":"Westropp JL, Sykes JE, Irom S, et al. Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs. J Vet Intern Med. 2012;26(3):506\u201312.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2974_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/jvim.12324","volume":"28","author":"S Clare","year":"2014","unstructured":"Clare S, Hartmann FA, Jooss M, et al. Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitis. J Vet Intern Med. 2014;28(3):818\u201326.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2974_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tvjl.2014.12.004","volume":"203","author":"LR Jessen","year":"2015","unstructured":"Jessen LR, S\u00f8rensen TM, Bjornvad CR, Nielsen SS, Guardabassi. L Effect of antimicrobial treatment in canine and feline urinary tract infections: a systematic review. Vet J. 2015;203(3):270\u20137.","journal-title":"Vet J"},{"key":"2974_CR30","doi-asserted-by":"crossref","unstructured":"Spellberg B. The New Antibiotic Mantra-\"Shorter Is Better\". JAMA Intern Med. 2016;176(9):1254-5.","DOI":"10.1001\/jamainternmed.2016.3646"},{"issue":"3","key":"2974_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.7326\/M19-1509","volume":"171","author":"B Spellberg","year":"2019","unstructured":"Spellberg B, Rice LB. Duration of antimicrobial therapy: shorter is better. Ann Intern Med. 2019;171(3):210\u20131.","journal-title":"Ann Intern Med"},{"key":"2974_CR32","doi-asserted-by":"publisher","first-page":"l440","DOI":"10.1136\/bmj.l440","volume":"364","author":"KB Pouwels","year":"2019","unstructured":"Pouwels KB, Hopkins S, Llewelyn MJ, Walker AS, et al. Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. BMJ. 2019;364:l440.","journal-title":"BMJ"},{"key":"2974_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7326\/M18-3640","volume":"171","author":"VM Vaughn","year":"2019","unstructured":"Vaughn VM, Flanders SA, Snyder A, et al. Excess antimicrobial treatment duration and adverse events in patients hospitalized with pneumonia. A multihospital cohort study. Ann Intern Med. 2019;171:153\u201363.","journal-title":"Ann Intern Med"},{"key":"2974_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12916-019-1348-z","volume":"17","author":"KB Pouwels","year":"2019","unstructured":"Pouwels KB, Yin M, Butler CC, et al. Optimising trial designs to identify appropriate antibiotic treatment durations. BMC Med. 2019;17:115.","journal-title":"BMC Med"},{"issue":"5","key":"2974_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1740774518778027","volume":"15","author":"M Quartagno","year":"2018","unstructured":"Quartagno M, Walker AS, Carpenter JR, Phillips PP, Parmar MK. Rethinking non-inferiority: a practical trial design for optimising treatment duration. Clin Trails. 2018;15(5):477\u201388.","journal-title":"Clin Trails"},{"issue":"6","key":"2974_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/1740774520944377","volume":"17","author":"M Quartagno","year":"2020","unstructured":"Quartagno M, Carpenter JR, Walker AS, Clements M, Parmar MK. The DURATIONS randomised trial design: Estimation targets, analysis methods and operating characteristics. Clin Trails. 2020;17(6):644\u201353.","journal-title":"Clin Trails"},{"key":"2974_CR37","doi-asserted-by":"crossref","unstructured":"Allerton F, Kent A. How to approach urinary tract infections. Companion 2020.","DOI":"10.22233\/20412495.0620.10"},{"key":"2974_CR38","unstructured":"Electronic Data Capture (EDC). eCRF, ePRO, eCOA for clinical research | Castor. In: Castor EDC. https:\/\/www.castoredc.com\/. Accessed 10 Dec 2020."},{"issue":"7","key":"2974_CR39","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/cid\/ciz103","volume":"69","author":"DR MacFadden","year":"2019","unstructured":"MacFadden DR, Hanage WP. Potential for Erosion of Efficacy in Noninferiority Trials of Decreasing Duration of Antibiotic Therapy. Clin Infect Dis. 2019;69(7):1262.","journal-title":"Clin Infect Dis"},{"issue":"543","key":"2974_CR40","first-page":"785","volume":"57","author":"CC Butler","year":"2007","unstructured":"Butler CC, Dunstan F, Heginbothom M, Mason B, Roberts Z, Hillier S, Howe R, Palmer S, Howard A. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract. 2007;57(543):785\u201392.","journal-title":"Br J Gen Pract"},{"issue":"20","key":"2974_CR41","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1001\/archinte.167.20.2201","volume":"167","author":"WJ McIsaac","year":"2007","unstructured":"McIsaac WJ, Moineddin R, Ross S. Validation of a decision aid to assist physicians in reducing unnecessary antibiotic drug use for acute cystitis. Arch Intern Med. 2007;167(20):2201\u20136.","journal-title":"Arch Intern Med"},{"key":"2974_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12875-017-0660-y","volume":"18","author":"WJ McIsaac","year":"2017","unstructured":"McIsaac WJ, Moineddin R, Gagyor I, Mazzulli T. External validation study of a clinical decision aid to reduce unnecessary antibiotic prescriptions in women with acute cystitis. BMC Fam Pract. 2017;18:89.","journal-title":"BMC Fam Pract"},{"issue":"20","key":"2974_CR43","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.287.20.2701","volume":"287","author":"S Bent","year":"2002","unstructured":"Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287(20):2701\u201310.","journal-title":"JAMA"},{"key":"2974_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2296-11-78","volume":"11","author":"LG Giesen","year":"2010","unstructured":"Giesen LG, Cousins G, Dimitrov BD, et al. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract. 2010;11:78.","journal-title":"BMC Fam Pract"},{"key":"2974_CR45","first-page":"340","volume":"129","author":"M Brloznik","year":"2016","unstructured":"Brloznik M, Sterk K, Zdovc I. Prevalence and resistance patterns of canine uropathogens in regard to concurrent diseases. Berl Munch Tierarztl Wochenschr. 2016;129:340\u201350.","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"2974_CR46","unstructured":"EMA\/AMEG, 2020. Categorisation of antibiotics in the European Union, https:\/\/www.ema.europa.eu\/en\/documents\/report\/categorisation-antibiotics-european-union-answer-request-european-commission-updating-scientific_en.pdf."},{"key":"2974_CR47","unstructured":"Veterinary Antimicrobial Resistance and Sales. Surveillance Report UK-VARSS. 2019 (2020). https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/942772\/FINAL_MASTER_VARSS_2019_Report__updated_Dec_2020_.pdf."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-02974-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-021-02974-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-02974-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:28:58Z","timestamp":1636392538000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-021-02974-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2974"],"URL":"https:\/\/doi.org\/10.1186\/s12917-021-02974-y","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is approved by the Ethical Review Board of the University of Nottingham (REF 3007 191023). An Animal Test Certificate (ATC-S-130) has been obtained from the Veterinary Medicines Directorate covering the use of formulations of amoxicillin-clavulanate with a marketing authorisation in the United Kingdom for a variable treatment duration. Informed consent will be obtained from all participating owners of dogs involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}